Evidence map›Paper›PMID 42315644›Full record

Trial reportNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2026

Acute and post-acute neurobehavioral responses to lysergic acid diethylamide in healthy subjects: a randomized controlled study.

Abigail E Calder, Vincent J Diehl, Morten P Lietz, Parsa Yousefi, Nicole Friedli, Fabio Coviello, Antonin Rouaud, Kristian Beichmann, Anne Eckert, Gregor Hasler

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Abigail E CalderMolecular Psychiatry Lab, Faculty of Science and Medicine, University of Fribourg, Villars-sur-Glâne, Switzerland. abigail.calder@unifr.ch.ORCID http://orcid.org/0000-0001-9528-404X
Vincent J DiehlMolecular Psychiatry Lab, Faculty of Science and Medicine, University of Fribourg, Villars-sur-Glâne, Switzerland.
Morten P LietzMolecular Psychiatry Lab, Faculty of Science and Medicine, University of Fribourg, Villars-sur-Glâne, Switzerland.
Parsa YousefiMolecular Psychiatry Lab, Faculty of Science and Medicine, University of Fribourg, Villars-sur-Glâne, Switzerland.
Nicole FriedliMolecular Psychiatry Lab, Faculty of Science and Medicine, University of Fribourg, Villars-sur-Glâne, Switzerland.ORCID http://orcid.org/0000-0002-7040-6909
Fabio CovielloMolecular Psychiatry Lab, Faculty of Science and Medicine, University of Fribourg, Villars-sur-Glâne, Switzerland.
Antonin RouaudMolecular Psychiatry Lab, Faculty of Science and Medicine, University of Fribourg, Villars-sur-Glâne, Switzerland.
Kristian BeichmannMolecular Psychiatry Lab, Faculty of Science and Medicine, University of Fribourg, Villars-sur-Glâne, Switzerland.ORCID http://orcid.org/0009-0000-0039-1302
Anne EckertNeurobiology Laboratory for Brain Aging and Mental Health, Psychiatric University Hospital, University of Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0002-9341-3669
Gregor HaslerMolecular Psychiatry Lab, Faculty of Science and Medicine, University of Fribourg, Villars-sur-Glâne, Switzerland.ORCID http://orcid.org/0000-0002-8311-0138

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Preclinical studies suggest that lysergic acid diethylamide (LSD) may induce lasting changes in brain function and learning ability, but evidence in humans is uncertain. Motor learning, in particular, has clinical relevance but has not been investigated in human studies of psychedelics. Forty-five healthy subjects (24 women) participated in this randomized crossover trial comparing 100 µg LSD with a placebo. For up to one week after dosing, we investigated LSD's post-acute neurophysiological effects using auditory tetanization with electroencephalography (EEG), paired associative stimulation (PAS) with transcranial magnetic stimulation (TMS), peripheral levels of brain-derived neurotrophic factor (BDNF). Additionally, online and offline motor learning were assessed one day after dosing with a sequence typing task. Questionnaires assessed perceived stress and cognitive flexibility one week after dosing. We found that offline motor learning significantly improved the day after LSD. One week after LSD, perceived stress was reduced and aspects of cognitive flexibility were increased. EEG data showed that LSD acutely decreased amplitudes of N1 and P2 auditory event-related potentials and still modulated P2 one week later. Motor-evoked potentials measured with TMS showed increased amplitude and faster latency under LSD. LSD did not alter BDNF levels. Our findings encourage future studies on LSD and learning and additionally highlight important challenges in the measurement of long-term potentiation in humans. The observed acute and lasting changes in neural signals provide insight into LSD's effects on the auditory and motor systems.

Indexed as

Evoked Potentials, MotorHallucinogensLearningLysergic Acid DiethylamideAdultBrain-Derived Neurotrophic FactorCognitive FlexibilityCross-Over StudiesDouble-Blind MethodElectroencephalographyEvoked Potentials, AuditoryFemaleHealthy VolunteersHumansMaleStress, PsychologicalBDNF protein, humanBrain-Derived Neurotrophic FactorHallucinogensLysergic Acid Diethylamide

Identifiers

PMID42315644
PMCPMC13389031

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.